Renal Biomarker Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025

Description

Persistence Market Research has recently released a comprehensive report on the worldwide market for renal biomarkers. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global renal biomarker market from 2025 to 2032.

Key Insights:

Renal Biomarker Market Size (2025E): USD 1.6 Billion
Projected Market Value (2032F): USD 2.7 Billion
Global Market Growth Rate (CAGR 2025 to 2032): 7.8%

Renal Biomarker Market - Report Scope:

Renal biomarkers are essential diagnostic tools that help in the early detection, monitoring, and management of kidney diseases, such as chronic kidney disease (CKD), acute kidney injury (AKI), and glomerulonephritis. These biomarkers help healthcare professionals assess kidney function, predict disease progression, and evaluate the efficacy of treatments. The renal biomarker market caters to a wide range of applications in clinical diagnostics, drug development, and personalized medicine. Market growth is driven by the increasing prevalence of kidney diseases, advancements in biomarker discovery, and the growing adoption of point-of-care diagnostic tools.

Market Growth Drivers:

The global renal biomarker market is propelled by several key factors, including the rising incidence of chronic kidney disease and acute kidney injury worldwide. The increasing burden of lifestyle diseases such as diabetes and hypertension, which are major risk factors for kidney disease, is further driving market expansion. Additionally, the development of new and more sensitive biomarkers, advancements in diagnostic technologies, and the growing focus on early detection and prevention of kidney disorders are expected to significantly enhance market growth. The increasing awareness of kidney diseases and the adoption of biomarker-based diagnostics in both developed and emerging markets contribute to the market's upward trajectory.

Market Restraints:

Despite promising growth prospects, the renal biomarker market faces challenges related to high diagnostic costs, regulatory hurdles, and limited reimbursement coverage for biomarker-based tests. The complexity of developing and validating new biomarkers can slow down the pace of innovation. Furthermore, the lack of standardized guidelines for the clinical application of renal biomarkers may pose challenges for healthcare providers in adopting these solutions. The affordability and accessibility of renal biomarker tests in low- and middle-income countries also remain a major barrier to widespread market penetration.

Market Opportunities:

The renal biomarker market presents significant growth opportunities driven by technological innovations, such as the development of point-of-care testing devices and the integration of artificial intelligence (AI) and machine learning for data analysis. Additionally, personalized medicine and the growing focus on precision healthcare offer new avenues for the application of renal biomarkers. The expansion of clinical research into kidney diseases, along with government initiatives aimed at increasing awareness and improving diagnosis, further promotes the market's growth. Strategic collaborations between biotechnology firms, research institutions, and healthcare providers are also expected to drive market innovation and expansion.

Key Questions Answered in the Report:

What are the primary factors driving the growth of the renal biomarker market globally?
Which renal biomarkers and diagnostic platforms are expected to gain significant adoption in the near future?
How are technological advancements in diagnostics reshaping the competitive landscape of the renal biomarker market?
Who are the key players contributing to the renal biomarker market, and what strategies are they employing to maintain market relevance?
What are the emerging trends and future prospects in the global renal biomarker market?

Competitive Intelligence and Business Strategy:

Leading players in the global renal biomarker market, including Abbott Laboratories, Thermo Fisher Scientific, and Siemens Healthineers, focus on innovation, product differentiation, and strategic partnerships to maintain their competitive edge. These companies are investing in R&D to develop novel biomarkers, improve existing diagnostic tools, and enhance the efficiency of clinical testing platforms. Collaborations with hospitals, research institutions, and pharmaceutical companies are helping market players to expand their product portfolios and gain access to new markets. Additionally, the integration of AI and machine learning into biomarker-based diagnostics is expected to revolutionize the market by improving accuracy and enabling earlier disease detection.

Key Companies Profiled:

Abbott Laboratories
SphingoTec GmbH
Thermo Fisher Scientific Inc.
NORDIC BIOSCIENCE
Siemens Healthineers AG
BIOMERIEUX
Randox Laboratories Ltd.
Sysmex Corporation
WebMD LLC.
Bio-Rad Laboratories, Inc.
Enzo Biochem Inc.
Proteomics International
SEKISUI MEDICAL CO., LTD.
BioPorto A/S
Hytest Ltd.
F. Hoffmann-La Roche Ltd.

Market Segmentation

By Product

Functional Biomarkers

* Serum Creatinine

* Blood Urea Nitrogen (BUN)

* Glomerular Filtration Rate (GFR)

Up Regulated Proteins

* Kidney Injury Molecule-1 (KIM-1)

* Neutrophil Gelatinase-Associated Lipocalin (NGAL)

* Interleukin-18 (IL-18)

Others

By Diagnostic Technique

Enzyme-Linked Immunosorbent Assay (ELISA)
Particle-Enhanced Turbidimetric Immunoassay (PETIA)
Colorimetric Assay
Chemiluminescent Enzyme Immunoassay (CLIA)
Liquid Chromatography-Mass Spectrometry (LC-MS)
Others

By End-use

Hospitals
Diagnostic Laboratories
Academic & Research Institutes
Others

By Region

North America
Europe
East Asia
South Asia and Oceania
Middle East and Africa
Latin America

Product Code: PMRREP35237

1. Executive Summary

1.1. Global Renal Biomarker Market Snapshot, 2025-2032
1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations

2. Market Overview

2.1. Market Scope and Definition
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunity
- 2.2.4. Key Trends
2.3. Macro-Economic Factors
- 2.3.1. Global Sectorial Outlook
- 2.3.2. Global GDP Growth Outlook
2.4. COVID-19 Impact Analysis
2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

3.1. Product Adoption Analysis
3.2. Regulatory Landscape
3.3. List of Suppliers
3.4. Porter's Five Forces Analysis
3.5. PESTLE Analysis
3.6. Promotional Strategies, By Key Players

4. Global Renal Biomarker Market Outlook

4.1. Key Highlights
- 4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
- 4.1.2. Absolute $ Opportunity
4.2. Market Size (US$ Bn) Analysis and Forecast
- 4.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
- 4.2.2. Market Size (US$ Bn) Analysis and Forecast, 2025-2032
4.3. Global Renal Biomarker Market Outlook: Product
- 4.3.1. Introduction / Key Findings
- 4.3.2. Historical Market Size (US$ Bn) Analysis, By Product, 2019-2024
- 4.3.3. Market Size (US$ Bn) Analysis and Forecast, By Product, 2025-2032
  - 4.3.3.1. Functional Biomarkers
    - 4.3.3.1.1. Serum Creatinine
    - 4.3.3.1.2. Blood Urea Nitrogen (BUN)
    - 4.3.3.1.3. Glomerular Filtration Rate (GFR)
  - 4.3.3.2. Upregulated Proteins
    - 4.3.3.2.1. Kidney Injury Molecule-1 (KIM-1)
    - 4.3.3.2.2. Neutrophil Gelatinase-Associated Lipocalin (NGAL)
    - 4.3.3.2.3. Interleukin-18 (IL-18)
  - 4.3.3.3. Others
- 4.3.4. Market Attractiveness Analysis: Product
4.4. Global Renal Biomarker Market Outlook: Diagnostic Technique
- 4.4.1. Introduction / Key Findings
- 4.4.2. Historical Market Size (US$ Bn) Analysis, By Diagnostic Technique, 2019-2024
- 4.4.3. Market Size (US$ Bn) Analysis and Forecast, By Diagnostic Technique, 2025-2032
  - 4.4.3.1. Enzyme-Linked Immunosorbent Assay (ELISA)
  - 4.4.3.2. Particle-Enhanced Turbidimetric Immunoassay (PETIA)
  - 4.4.3.3. Colorimetric Assay
  - 4.4.3.4. Chemiluminescent Enzyme Immunoassay (CLIA)
  - 4.4.3.5. Liquid Chromatography-Mass Spectrometry (LC-MS)
  - 4.4.3.6. Others
- 4.4.4. Market Attractiveness Analysis: Technology
4.5. Global Renal Biomarker Market Outlook: End User
- 4.5.1. Introduction / Key Findings
- 4.5.2. Historical Market Size (US$ Bn) Analysis, By End User, 2019-2024
- 4.5.3. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
  - 4.5.3.1. Hospitals
  - 4.5.3.2. Diagnostic Laboratories
  - 4.5.3.3. Academic & Research Institutes
  - 4.5.3.4. Others
- 4.5.4. Market Attractiveness Analysis: End User

5. Global Renal Biomarker Market Outlook: Region

5.1. Key Highlights
5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2024
5.3. Market Size (US$ Bn) Analysis and Forecast, By Region, 2025-2032
- 5.3.1. North America
- 5.3.2. Europe
- 5.3.3. East Asia
- 5.3.4. South Asia and Oceania
- 5.3.5. Latin America
- 5.3.6. Middle East & Africa
5.4. Market Attractiveness Analysis: Region

6. North America Renal Biomarker Market Outlook

6.1. Key Highlights
6.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 6.2.1. By Country
- 6.2.2. By Product
- 6.2.3. By Diagnostic Technique
- 6.2.4. By End User
6.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 6.3.1. U.S.
- 6.3.2. Canada
6.4. Market Size (US$ Bn) Analysis and Forecast, By Product, 2025-2032
- 6.4.1. Functional Biomarkers
  - 6.4.1.1. Serum Creatinine
  - 6.4.1.2. Blood Urea Nitrogen (BUN)
  - 6.4.1.3. Glomerular Filtration Rate (GFR)
- 6.4.2. Upregulated Proteins
  - 6.4.2.1. Kidney Injury Molecule-1 (KIM-1)
  - 6.4.2.2. Neutrophil Gelatinase-Associated Lipocalin (NGAL)
  - 6.4.2.3. Interleukin-18 (IL-18)
- 6.4.3. Others
6.5. Market Size (US$ Bn) Analysis and Forecast, By Diagnostic Technique, 2025-2032
- 6.5.1. Enzyme-Linked Immunosorbent Assay
- 6.5.2. Particle-Enhanced Turbidimetric Immunoassay (PETIA)
- 6.5.3. Colorimetric Assay
- 6.5.4. Chemiluminescent Enzyme Immunoassay (CLIA)
- 6.5.5. Liquid Chromatography-Mass Spectrometry (LC-MS)
- 6.5.6. Others
6.6. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
- 6.6.1. Hospitals
- 6.6.2. Diagnostic Laboratories
- 6.6.3. Academic & Research Institutes
- 6.6.4. Others
6.7. Market Attractiveness Analysis

7. Europe Renal Biomarker Market Outlook

7.1. Key Highlights
7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 7.2.1. By Country
- 7.2.2. By Product
- 7.2.3. By Diagnostic Technique
- 7.2.4. By End User
7.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 7.3.1. Germany
- 7.3.2. France
- 7.3.3. U.K.
- 7.3.4. Italy
- 7.3.5. Spain
- 7.3.6. Russia
- 7.3.7. Turkey
- 7.3.8. Rest of Europe
7.4. Market Size (US$ Bn) Analysis and Forecast, By Product, 2025-2032
- 7.4.1. Functional Biomarkers
  - 7.4.1.1. Serum Creatinine
  - 7.4.1.2. Blood Urea Nitrogen (BUN)
  - 7.4.1.3. Glomerular Filtration Rate (GFR)
- 7.4.2. Upregulated Proteins
  - 7.4.2.1. Kidney Injury Molecule-1 (KIM-1)
  - 7.4.2.2. Neutrophil Gelatinase-Associated Lipocalin (NGAL)
  - 7.4.2.3. Interleukin-18 (IL-18)
- 7.4.3. Others
7.5. Market Size (US$ Bn) Analysis and Forecast, By Diagnostic Technique, 2025-2032
- 7.5.1. Enzyme-Linked Immunosorbent Assay
- 7.5.2. Particle-Enhanced Turbidimetric Immunoassay (PETIA)
- 7.5.3. Colorimetric Assay
- 7.5.4. Chemiluminescent Enzyme Immunoassay (CLIA)
- 7.5.5. Liquid Chromatography-Mass Spectrometry (LC-MS)
- 7.5.6. Others
7.6. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
- 7.6.1. Hospitals
- 7.6.2. Diagnostic Laboratories
- 7.6.3. Academic & Research Institutes
- 7.6.4. Others
7.7. Market Attractiveness Analysis

8. East Asia Renal Biomarker Market Outlook

8.1. Key Highlights
8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 8.2.1. By Country
- 8.2.2. By Product
- 8.2.3. By Diagnostic Technique
- 8.2.4. By End User
8.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 8.3.1. China
- 8.3.2. Japan
- 8.3.3. South Korea
8.4. Market Size (US$ Bn) Analysis and Forecast, By Product, 2025-2032
- 8.4.1. Functional Biomarkers
  - 8.4.1.1. Serum Creatinine
  - 8.4.1.2. Blood Urea Nitrogen (BUN)
  - 8.4.1.3. Glomerular Filtration Rate (GFR)
- 8.4.2. Upregulated Proteins
  - 8.4.2.1. Kidney Injury Molecule-1 (KIM-1)
  - 8.4.2.2. Neutrophil Gelatinase-Associated Lipocalin (NGAL)
  - 8.4.2.3. Interleukin-18 (IL-18)
- 8.4.3. Others
8.5. Market Size (US$ Bn) Analysis and Forecast, By Diagnostic Technique, 2025-2032
- 8.5.1. Enzyme-Linked Immunosorbent Assay
- 8.5.2. Particle-Enhanced Turbidimetric Immunoassay (PETIA)
- 8.5.3. Colorimetric Assay
- 8.5.4. Chemiluminescent Enzyme Immunoassay (CLIA)
- 8.5.5. Liquid Chromatography-Mass Spectrometry (LC-MS)
- 8.5.6. Others
8.6. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
- 8.6.1. Hospitals
- 8.6.2. Diagnostic Laboratories
- 8.6.3. Academic & Research Institutes
- 8.6.4. Others
8.7. Market Attractiveness Analysis

9. South Asia & Oceania Renal Biomarker Market Outlook

9.1. Key Highlights
9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 9.2.1. By Country
- 9.2.2. By Product
- 9.2.3. By Diagnostic Technique
- 9.2.4. By End User
9.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 9.3.1. India
- 9.3.2. Southeast Asia
- 9.3.3. ANZ
- 9.3.4. Rest of South Asia & Oceania
9.4. Market Size (US$ Bn) Analysis and Forecast, By Product, 2025-2032
- 9.4.1. Functional Biomarkers
  - 9.4.1.1. Serum Creatinine
  - 9.4.1.2. Blood Urea Nitrogen (BUN)
  - 9.4.1.3. Glomerular Filtration Rate (GFR)
- 9.4.2. Upregulated Proteins
  - 9.4.2.1. Kidney Injury Molecule-1 (KIM-1)
  - 9.4.2.2. Neutrophil Gelatinase-Associated Lipocalin (NGAL)
  - 9.4.2.3. Interleukin-18 (IL-18)
- 9.4.3. Others
9.5. Market Size (US$ Bn) Analysis and Forecast, By Diagnostic Technique, 2025-2032
- 9.5.1. Enzyme-Linked Immunosorbent Assay
- 9.5.2. Particle-Enhanced Turbidimetric Immunoassay (PETIA)
- 9.5.3. Colorimetric Assay
- 9.5.4. Chemiluminescent Enzyme Immunoassay (CLIA)
- 9.5.5. Liquid Chromatography-Mass Spectrometry (LC-MS)
- 9.5.6. Others
9.6. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
- 9.6.1. Hospitals
- 9.6.2. Diagnostic Laboratories
- 9.6.3. Academic & Research Institutes
- 9.6.4. Others
9.7. Market Attractiveness Analysis

10. Latin America Renal Biomarker Market Outlook

10.1. Key Highlights
10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 10.2.1. By Country
- 10.2.2. By Product
- 10.2.3. By Diagnostic Technique
- 10.2.4. By End User
10.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 10.3.1. Brazil
- 10.3.2. Mexico
- 10.3.3. Rest of Latin America
10.4. Market Size (US$ Bn) Analysis and Forecast, By Product, 2025-2032
- 10.4.1. Functional Biomarkers
  - 10.4.1.1. Serum Creatinine
  - 10.4.1.2. Blood Urea Nitrogen (BUN)
  - 10.4.1.3. Glomerular Filtration Rate (GFR)
- 10.4.2. Upregulated Proteins
  - 10.4.2.1. Kidney Injury Molecule-1 (KIM-1)
  - 10.4.2.2. Neutrophil Gelatinase-Associated Lipocalin (NGAL)
  - 10.4.2.3. Interleukin-18 (IL-18)
- 10.4.3. Others
10.5. Market Size (US$ Bn) Analysis and Forecast, By Diagnostic Technique, 2025-2032
- 10.5.1. Enzyme-Linked Immunosorbent Assay
- 10.5.2. Particle-Enhanced Turbidimetric Immunoassay (PETIA)
- 10.5.3. Colorimetric Assay
- 10.5.4. Chemiluminescent Enzyme Immunoassay (CLIA)
- 10.5.5. Liquid Chromatography-Mass Spectrometry (LC-MS)
- 10.5.6. Others
10.6. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
- 10.6.1. Hospitals
- 10.6.2. Diagnostic Laboratories
- 10.6.3. Academic & Research Institutes
- 10.6.4. Others
10.7. Market Attractiveness Analysis

11. Middle East & Africa Renal Biomarker Market Outlook

11.1. Key Highlights
11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
- 11.2.1. By Country
- 11.2.2. By Product
- 11.2.3. By Diagnostic Technique
- 11.2.4. By End User
11.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
- 11.3.1. GCC Countries
- 11.3.2. Egypt
- 11.3.3. South Africa
- 11.3.4. Northern Africa
- 11.3.5. Rest of Middle East & Africa
11.4. Market Size (US$ Bn) Analysis and Forecast, By Product, 2025-2032
- 11.4.1. Functional Biomarkers
  - 11.4.1.1. Serum Creatinine
  - 11.4.1.2. Blood Urea Nitrogen (BUN)
  - 11.4.1.3. Glomerular Filtration Rate (GFR)
- 11.4.2. Upregulated Proteins
  - 11.4.2.1. Kidney Injury Molecule-1 (KIM-1)
  - 11.4.2.2. Neutrophil Gelatinase-Associated Lipocalin (NGAL)
  - 11.4.2.3. Interleukin-18 (IL-18)
- 11.4.3. Others
11.5. Market Size (US$ Bn) Analysis and Forecast, By Diagnostic Technique, 2025-2032
- 11.5.1. Enzyme-Linked Immunosorbent Assay
- 11.5.2. Particle-Enhanced Turbidimetric Immunoassay (PETIA)
- 11.5.3. Colorimetric Assay
- 11.5.4. Chemiluminescent Enzyme Immunoassay (CLIA)
- 11.5.5. Liquid Chromatography-Mass Spectrometry (LC-MS)
- 11.5.6. Others
11.6. Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
- 11.6.1. Hospitals
- 11.6.2. Diagnostic Laboratories
- 11.6.3. Academic & Research Institutes
- 11.6.4. Others
11.7. Market Attractiveness Analysis

12. Competition Landscape

12.1. Market Share Analysis, 2025
12.2. Market Structure
- 12.2.1. Competition Intensity Mapping By Market
- 12.2.2. Competition Dashboard
12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
- 12.3.1. Abbott Laboratories
  - 12.3.1.1. Overview
  - 12.3.1.2. Segments and Products
  - 12.3.1.3. Key Financials
  - 12.3.1.4. Market Developments
  - 12.3.1.5. Market Strategy
- 12.3.2. SphingoTec GmbH
- 12.3.3. Thermo Fisher Scientific Inc.
- 12.3.4. NORDIC BIOSCIENCE
- 12.3.5. Siemens Healthineers AG
- 12.3.6. BIOMERIEUX
- 12.3.7. Randox Laboratories Ltd.
- 12.3.8. Sysmex Corporation
- 12.3.9. WebMD LLC.
- 12.3.10. Bio-Rad Laboratories, Inc.
- 12.3.11. Enzo Biochem Inc.
- 12.3.12. Proteomics International
- 12.3.13. SEKISUI MEDICAL CO., LTD.
- 12.3.14. BioPorto A/S
- 12.3.15. Hytest Ltd.
- 12.3.16. F. Hoffmann-La Roche Ltd.

13. Appendix

13.1. Research Methodology
13.2. Research Assumptions
13.3. Acronyms and Abbreviations

Renal Biomarker Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032